Clinical Trial Update: Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II trial comparing XP versus XG in advanced esophageal squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• XG
• XP

Snippet

Sponsor: Samsung Medical Center | Conditions: Advanced or Recurrent Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED